The elevated enhancer of zeste homolog 2 (EZH2, an epigenetic regulator) in CD4+ T cells facilitated CXCR5+PD-1+ cTfh cell differentiation by enhancing STAT3 phosphorylation in SS patients (127). This evidence concerns the gene CD4 and synovial sarcoma.